| Ytd | 42.62% | |
| 1y | 11.69% |
| Open | 9.20 | Prev Close | 9.16 | Low | 9.01 | High | 9.37 | Mkt Cap | 201.88M |
| Vol | 215.62K | Avg Vol | 98.11K | EPS | -0.96 | P/E | N/A | Forward P/E | N/A |
| Beta | 2.31 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 8.34 | 200-d Avg | 6.53 | 1yr Est | 0.00 |
Top Wall Street analysts updated ratings on SPHR, CVLG, MIST, MSGE,. Check out analyst ratings page
B. Riley Securities analyst William Woods initiates coverage on Alpha Cognition (NASDAQ:ACOG) wit
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Alpha Cognition (NASDAQ:ACOG) with a
Dallas, Texas--(Newsfile Corp. - August 17, 2026) - Alpha Cognition Inc. (NASDAQ: ACOG): Stonegate C
Alpha Cognition Inc. (ACOG) Q2 2026 Earnings Call Transcript
Alpha Cognition Inc. (ACOG) came out with a quarterly loss of $0.4 per share versus the Zacks Consen
Alpha Cognition NASDAQ: ACOG reported second-quarter 2026 net product revenue of approximately $6 mi
Alpha Cognition (NASDAQ:ACOG) reported second-quarter financial results on Thursday. The transcript
Alpha Cognition (NASDAQ:ACOG) reported quarterly losses of $(0.40) per share which missed the analys
VANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)--Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha C
Alpha Cognition Inc. (ACOG) possesses the right combination of the two key ingredients for a likely
VANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG), a biopha
VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Alpha Cognition Inc. (NASDAQ: ACOG)
Alpha Cognition Inc. (ACOG) witnessed a jump in share price last session on above-average trading vo
Biotech stocks are consolidating after a breakout, with bullish insider Wall Street sentiment. AbCel
VANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha C
Wall Street analysts changed outlook on top names. See all changes on analyst ratings page. Consider
Raymond James analyst Ryan Deschner initiates coverage on Alpha Cognition (NASDAQ:ACOG) with a Ou
Alpha Cognition Inc. (Nasdaq: ACOG) (âAlpha Cognitionâ, or the âCompanyâ), a biopharmaceutic
Alpha Cognition Inc. (Nasdaq: ACOG) ("Alpha Cognition", or the "Company"), a biophar
VANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha C
Alpha Cognition, Inc. (ACOG: NASDAQ) ("Alpha Cognition" or the "Company"), a biophar
VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Alpha Cognition, Inc. (ACOG: NASDAQ
Providers reported cognitive improvement in 92% of patients following initiation of ZUNVEYLProvider
Alpha Cognition Inc. (NASDAQ: ACOG) (âAlpha Cognitionâ, âACIâ, or the âCompanyâ), a biop
VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Alpha Cognition Inc. (NASDAQ: ACOG)
Alpha Cognition Inc. (ACOG) Q1 2026 Earnings Call Transcript
Alpha Cognition Inc. (ACOG) came out with a quarterly loss of $0.37 per share versus the Zacks Conse
Alpha Cognition NASDAQ: ACOG reported 40% sequential revenue growth in the first quarter of 2026, as
VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Alpha Cognition Inc. (ACOG: NASDAQ)